Aromatase deficiency inhibits the permeability transition in mouse liver mitochondria

Endocrinology

Volumn 151, Issue 4, 2010, Pages 1643-1652

  Moro, Loredana ^a,b   Arbini, Arnaldo A ^b   Hsieh, Jer Tsong ^b,c   Ford, Jeffery ^b   Simpson, Evan R ^d   Hajibeigi, Asghar ^b   Öz, Orhan K ^b  

^a CNR   (Italy)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; AROMATASE; CALCIUM; CARDIOLIPIN; CYCLOSPORIN A; CYTOCHROME C OXIDASE; MESSENGER RNA; MITOCHONDRIAL PROTEIN; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; LIPID STORAGE; LIVER METABOLISM; LIVER MITOCHONDRION; MALE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENINE NUCLEOTIDE TRANSLOCATOR 2; ADENOSINE TRIPHOSPHATE; ANALYSIS OF VARIANCE; ANIMALS; AROMATASE; BLOTTING, WESTERN; CARDIOLIPINS; CELL FRACTIONATION; ELECTRON TRANSPORT COMPLEX IV; ESTRADIOL; FATTY LIVER; LIVER; MALE; MICE; MICE, KNOCKOUT; MITOCHONDRIA, LIVER; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL MEMBRANES; ORGAN SIZE; PERMEABILITY; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77950217697     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1450     Document Type: Article

References (66)

1. Jones ME, Boon WC, Proietto J, Simpson ER 2006 Of mice and men: the evolving phenotype of aromatase deficiency. Trends Endocrinol Metab 17:55-64
2. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER 2000 Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97:12735-12740
3. Hewitt KN, Pratis K, Jones ME, Simpson ER 2004 Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology 145:1842-1848
4. Nemoto Y, Toda K, Ono M, Fujikawa-Adachi K, Saibara T, Onishi S, Enzan H, Okada T, Shizuta Y 2000 Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin Invest 105:1819-1825
5. Toda K, Takeda K, Akira S, Saibara T, Okada T, Onishi S, Shizuta Y 2001 Alternations in hepatic expression of fatty-acid metabolizing enzymes in ArKO mice and their reversal by the treatment with 17β-estradiol or a peroxisome proliferator. J Steroid Biochem Mol Biol 79:11-17
6. Pura M, Mittre H, Carreau S, Kottler ML, Clinical findings in an adult man with a novel mutation in the aromatase gene. Program of the 85th Annual Meeting of The Endocrine Society, Philadelphia, 2003, p 248 (Abstract P1-467)
7. Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M, Clyne CD, Davis S, Simpson ER, Carani C 2004 Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab 89:61-70
8. Maffei L, Rochira V, Zirilli L, Antunez P, Aranda C, Fabre B, Simone ML, Pignatti E, Simpson ER, Houssami S, Clyne CD, Carani C 2007 A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome. Clin Endocrinol (Oxf) 67:218-224
9. McBride HM, Neuspiel M, Wasiak S 2006 Mitochondria: more than just a powerhouse. Curr Biol 16:R551-R560
10. Moro L, Arbini AA, Marra E, Greco M 2008 Mitochondrial DNA depletion reduces PARP-1 levels and promotes progression of the neoplastic phenotype in prostate carcinoma. Cell Oncol 30:307-322
11. Moro L, Arbini AA, Yao JL, di Sant'Agnese PA, Marra E, Greco M 2009 Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/ Akt2. Cell Death Differ 16:571-583
12. Bernardi P, Broekemeier KM, Pfeiffer DR 1994 Recent progress on regulation of the mitochondrial permeability transition pore; a cyclosporin-sensitive pore in the inner mitochondrial membrane. J Bioenerg Biomembr 26:509-517
13. Gunter TE, Gunter KK, Sheu SS, Gavin CE 1994 Mitochondrial calcium transport: physiological and pathological relevance. Am J Physiol 267:C313-C339
14. Hirsch T, Marzo I, Kroemer G 1997 Role of the mitochondrial permeability transition pore in apoptosis. Biosci Rep 17:67-76
15. Lemasters JJ 2007 Modulation of mitochondrial membrane permeability in pathogenesis, autophagy and control of metabolism. J Gastroenterol Hepatol 22(Suppl 1):S31-S37
16. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD 1997 The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136
17. Tsujimoto Y, Shimizu S 2007 Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 12:835-840
18. Lieser MJ, Park J, Natori S, Jones BA, Bronk SF, Gores GJ 1998 Cholestasis confers resistance to the rat liver mitochondrial permeability transition. Gastroenterology 115:693-701
19. Klingenberg M 2009 Cardiolipin and mitochondrial carriers. Biochim Biophys Acta 1788:2048-2058
20. 2+- induced reactive oxygen species production promotes cytochrome c release from rat liver mitochondria via mitochondrial permeability transition (MPT)-dependent and MPT-independent mechanisms: role of cardiolipin. J Biol Chem 279:53103-53108
21. Vacca RA, Moro L, Caraccio G, Guerrieri F, Marra E, Greco M 2003 Thyroid hormone administration to hypothyroid rats restores the mitochondrial membrane permeability properties. Endocrinology 144:3783-3788
22. Moro L, Marra E, Capuano F, Greco M 2004 Thyroid hormone treatment of hypothyroid rats restores the regenerative capacity and the mitochondrial membrane permeability properties of the liver after partial hepatectomy. Endocrinology 145:5121-5128
23. Fisher CR, Graves KH, Parlow AF, Simpson ER 1998 Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci USA 95:6965-6970
24. Robertson KM, O'Donnell L, Jones ME, Meachem SJ, Boon WC, Fisher CR, Graves KH, McLachlan RI, Simpson ER 1999 Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene. Proc Natl Acad Sci USA 96:7986-7991
25. Folch J, Lees M, Sloane Stanley GH 1957 A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509
26. Ametaj BN, Bobe G, Lu Y, Young JW, Beitz DC 2003 Effect of sample preparation, length of time, and sample size on quantification of total lipids from bovine liver. J Agric Food Chem 51:2105-2110
27. Ragan CY, Wilson MT, Darley-Usmar VM, Lowe PN 1987 Subfractionation of mitochondria: an isolation of the proteins of oxidative phosphorylation. In: Darley-Usmar VM, Rickwood D, Wilson MT, eds. Mitochondria: a practical approach. Oxford, UK: IRL Press; 79-112
28. Massey V 1959 The microestimation of succinate and the extinction coefficient of cytochrome c. Biochim Biophys Acta 34:255-256
29. Akerman KE, Wikström MK 1976 Safranine as a probe of the mitochondrial membrane potential. FEBS Lett 68:191-197
30. Petit JM, Huet O, Gallet PF, Maftah A, Ratinaud MH, Julien R 1994 Direct analysis and significance of cardiolipin transverse distribution in mitochondrial inner membranes. Eur J Biochem 220:871-879
31. Shabalina IG, Kramarova TV, Nedergaard J, Cannon B 2006 Carboxyatractyloside effects on brown-fat mitochondria imply that the adenine nucleotide translocator isoforms ANT1 and ANT2 may be responsible for basal and fatty-acid-induced uncoupling respectively. Biochem J 399:405-414
32. 2+ and ROS. Front Biosci 14:1197-1218
33. Broekemeier KM, Dempsey ME, Pfeiffer DR 1989 Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem 264:7826-7830
34. Bauer MK, Schubert A, Rocks O, Grimm S 1999 Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis. J Cell Biol 147:1493-1502
35. Le Bras M, Borgne-Sanchez A, Touat Z, El Dein OS, Deniaud A, Maillier E, Lecellier G, Rebouillat D, Lemaire C, Kroemer G, Jacotot E, Brenner C 2006 Chemosensitization by knockdown of adenine nucleotide translocase-2. Cancer Res 66:9143-9152
36. Jang JY, Choi Y, Jeon YK, Aung KC, Kim CW 2008 Over-expression of adenine nucleotide translocase 1 (ANT1) induces apoptosis and tumor regression in vivo. BMC Cancer 8:160
37. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP, MacGregor GR, Wallace DC 2004 TheADP/ATPtranslocator is not essential for the mitochondrial permeability transition pore. Nature 427:461-465
38. Brenner C, Le Bras M, Kroemer G 2003 Insights into the mitochondrial signaling pathway: what lessons for chemotherapy? J Clin Immunol 23:73-80
39. Mandlekar S, Kong AN 2001 Mechanisms of tamoxifen-induced apoptosis. Apoptosis 6:469-477
40. Law CH, Tandan VR 1999 The association between tamoxifen and the development of hepatocellular carcinoma: case report and literature review. Can J Surg 42:211-214
41. White IN 1999 The tamoxifen dilemma. Carcinogenesis 20:1153-1160
42. Moffat DF, Oien KA, Dickson J, Habeshaw T, McLellan DR 2000 Hepatocellular carcinoma after long-term tamoxifen therapy. Ann Oncol 11:1195-1196
43. 2+ and inorganic phosphate. Toxicol Appl Pharmacol 152:10-17
44. Sakurai K, Katoh M, Fujimoto Y 2001 Alloxan-induced mitochondrial permeability transition triggered by calcium, thiol oxidation, and matrix ATP. J Biol Chem 276:26942-26946
45. Le Bras M, Clément MV, Pervaiz S, Brenner C 2005 Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol Histopathol 20:205-219
46. Shoubridge EA 2001 Cytochrome c oxidase deficiency. Am J Med Genet 106:46-52
47. Li Y, Park JS, Deng JH, Bai Y 2006 Cytochrome c oxidase subunit IV is essential for assembly and respiratory function of the enzyme complex. J Bioenerg Biomembr 38:283-291
48. Moreira PI, Custódio J, Moreno A, Oliveira CR, Santos MS 2006 Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure. J Biol Chem 281: 10143-10152
49. Moreira PI, Custódio JB, Nunes E, Moreno A, Seiça R, Oliveira CR, Santos MS 2007 Estradiol affects liver mitochondrial function in ovariectomized and tamoxifen-treated ovariectomized female rats. Toxicol Appl Pharmacol 221:102-110
50. Hewitt KN, Boon WC, Murata Y, Jones ME, Simpson ER 2003 The aromatase knockout mouse presents with a sexually dimorphic disruption to cholesterol homeostasis. Endocrinology 144:3895-3903
51. Robinson NC 1993 Functional binding of cardiolipin to cytochrome c oxidase. J Bioenerg Biomembr 25:153-163
52. Garcia Fernandez M, Troiano L, Moretti L, Nasi M, Pinti M, Salvioli S, Dobrucki J, Cossarizza A 2002 Early changes in intramitochondrial cardiolipin distribution during apoptosis. Cell Growth Differ 13:449-455
53. Hoffmann B, Stöckl A, Schlame M, Beyer K, Klingenberg M 1994 The reconstituted ADP/ATP carrier activity has an absolute requirement for cardiolipin as shown in cysteine mutants. J Biol Chem 269:1940-1944
54. Lutter M, Fang M, Luo X, Nishijima M, Xie X, Wang X 2000 Cardiolipin provides specificity for targeting of tBid to mitochondria. Nat Cell Biol 2:754-761
55. Petit PX, Lecoeur H, Zorn E, Dauguet C, Mignotte B, Gougeon ML 1995 Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol 130:157-167
56. Ferreira FM, Seiça R, Oliveira PJ, Coxito PM, Moreno AJ, Palmeira CM, Santos MS 2003 Diabetes induces metabolic adaptations in rat liver mitochondria: role of coenzyme Q and cardiolipin contents. Biochim Biophys Acta 1639:113-120
57. Kowaltowski AJ, Vercesi AE, Fiskum G 2000 Bcl-2 prevents mitochondrial permeability transition and cytochrome c release via maintenance of reduced pyridine nucleotides. Cell Death Differ 7:903-910
58. Reed JC, Jurgensmeier JM, Matsuyama S 1998 Bcl-2 family proteins and mitochondria. Biochim Biophys Acta 1366:127-137
59. Subramanian M, Shaha C 2007 Up-regulation of Bcl-2 through ERK phosphorylation is associated with human macrophage survival in an estrogen microenvironment. J Immunol 179:2330-2338
60. Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, Klinge CM 2009 Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res 37:2584-2595
61. Fan L, Pandey SC, Cohen RS 2008 Estrogen affects levels of Bcl-2 protein and mRNA in medial amygdala of ovariectomized rats. J Neurosci Res 86:3655-3664
62. Zhi X, Honda K, Sumi T, Yasui T, Nobeyama H, Yoshida H, Ishiko O 2007 Estradiol-17β regulates vascular endothelial growth factor and Bcl-2 expression in HHUA cells. Int J Oncol 31:1333-1338
63. Giraud S, Bonod-Bidaud C, Wesolowski-Louvel M, Stepien G 1998 Expression of human ANT2 gene in highly proliferative cells: GRBOX, anewtranscriptional element, is involved in the regulation of glycolytic ATP import into mitochondria. J Mol Biol 281:409-418
64. Lunardi J, Attardi G 1991 Differential regulation of expression of the multiple ADP/ATP translocase genes in human cells. J Biol Chem 266:16534-16540
65. Yang S, Lin HZ, Hwang J, Chacko VP, Diehl AM 2001 Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res 61:5016-5023
66. Pekow JR, Bhan AK, Zheng H, Chung RT 2007 Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer 109:2490-2496